△◠○◡◇ Fabulations
▩ Approaches
<<<< about:: >>>>
ʬʭ Multi Filter
- Materials
  Approaches
  Fabulations
  People/Orgs
  Bits of Narration

⌕⌕ Search Materials

84 object Results

Sort by:

Identifier

Title

Sort order:

Ascending
Descending

Start Over

Download results as:

Checklist
PDF (thumbnails)
Excel (basic information)
PowerPoint (basic information)

approach:

2B5A8FNL
Ribavirin's antiviral mechanism of action: lethal mutagenesis?

3FVVRMQQ
Neue Hepatitis-C-Therapie ist der Schweiz zu teuer

3NS5GHDA
Regeln gebogen, der Patient lebt

3WKY2ADL
Treatment of Chronic Hepatitis C with Different Genotypes

4EI34FI7
Enter Sofosbuvir: The Path to Curing HCV

4F47FSC7
Wyden-Grassley Sovaldi Investigation Finds Revenue-Driven Pricing Strategy Behind $84,000 Hepatitis Drug | The United States Senate Committee on Finance

4KKFSFFR
Cardiovascular Manifestations of Hepatitis C Virus

4Y9NU73P
Treatment of hepatitis C

4YL6HXGC
Candidate cause identified of non-A, non-B hepatitis

6HCBV9BF
Expert Committee on Selection and Use of Essential Medicines

6PEIRMWD
Die Biotechnologie-Industrie

6TBU5JNX
Tour n' Cure

7IIK6K2E
Making PCR: A Story of Biotechnology

8MDBEQ5V
Egypt will not patent new hepatitis C drug

8RY62W47
Construction of Biologically Functional Bacterial Plasmids In Vitro

8T38RKZT
Gilead could have had Pharmasset cheap: founder

9AEWQY7B
Theresa Rohner und Mitbeteiligte gegen Kanton Appenzell I.Rh., BGE 116 IA 359 (1990)

9CNBJYLN
Collective Efforts By Civil Society Groups Bar The Way To Hepatitis C Patents

9XRY8YCV
Bundesverfassung der Schweizerischen Eidgenossenschaft vom 18. April 1999 (Stand am 23. September 2018)

46NB3RLE
Forschungsethik: Eine Einführung

64SGFLGS
WTO | Ministerial conferences - Doha 4th Ministerial - TRIPS declaration

69N5ZFVM
The Penrose Inquiry: final report.

262SGMXZ
Zur Transposition des Lebens im Zeitalter des genetischen Biokapitalismus

482I8PTK
A Brief History of Hepatitis C

583LX36R
eEML - Electronic Essential Medicines List

3944SKY5
Diamond v. Chakrabarty, 447 U.S. 303 (1980)

AJU7Y3DZ
The Price of Sovaldi and its Impact on the U.S. Health Care System

BBIBMCWL
Introduction to hepatitis C virus infection: Overview and history of hepatitis C virus therapies: Overview and history of hepatitis C therapies

BEIG4WWC
Gilead Announces Generic Licensing Agreements to Increase Access to Hepatitis C Treatments in Developing Countries

BL2XRXB8
One year after Sovaldi: Why Egypt needs billions to beat Hepatitis C - Features

D3WC64GP
Molekulare Virologie

D3XLD228
17.3027 | Ist die Sicherheit der Medikamente auf dem Gesundheitsmarkt Schweiz noch gewährleistet?

DLIJKZGY
Gilead to Buy Pharmasset for $11 Billion

DW2PLUD2
Recombinant interferon - the 20th anniversary

EL7E88HF
PHARMASSET INC FORM 10-K (Annual Report): Filed 12/31/07 for the Period Ending 09/30/07

F4Q2YW24
Extrahepatic manifestations of chronic hepatitis C virus infection

Filter by

object type

Book Sections (4)

Conference Papers (1)

Journal Articles (26)

Newspaper Articles (8)

Video Recordings (1)

person

United States Securities and Exchange Commission (SEC) (1)

Abaza, Deya (1)

HCV Advocate (1)

Aeple, Natalia (1)

Andino, Raul (1)

Atlan, Henri (1)